Resultados de la búsqueda 271-280 of 8858 for Assay

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Circulating Tumor DNA (cTDNA) Based in NGS (Next Generation Sequencing) Assays for Oncology Patients With Solid Tumors ... assays and results from a ctDNA assay ...

  2. Oncología (médica) - Ensayos clínicos

    Circulating Tumor DNA (cTDNA) Based in NGS (Next Generation Sequencing) Assays for Oncology Patients With Solid Tumors ... assays and results from a ctDNA assay ...

  3. Medicina interna general - Ensayos clínicos

    This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    ... assay. A database of paired clinical and sequencing data will also be established for future research. A Study to Evaluate APG2575 Combined with Novel ...

  5. Oncología (médica) - Ensayos clínicos

    Circulating Tumor DNA (cTDNA) Based in NGS (Next Generation Sequencing) Assays for Oncology Patients With Solid Tumors ... assays and results from a ctDNA assay ...

  6. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...

  7. Oncología (médica) - Ensayos clínicos

    Circulating Tumor DNA (cTDNA) Based in NGS (Next Generation Sequencing) Assays for Oncology Patients With Solid Tumors ... assays and results from a ctDNA assay ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...